Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
Guest: Dr. Lucinda Whitney When corticosteroid risks come up, most clinicians immediately think about osteoporosis, hyperglycemia, infection risk, or adrenal suppression. But what about the organ sitting between the ears?…
This Hyperpigmentation and Melasma Awareness Month, access the peer-reviewed data, treatment guidelines, and clinical pearls your practice needs now As the peak summer sun amplifies patient concerns over dark spots,…
Search Interest in Hyperpigmentation Is Rising and Dermatology Professionals Should Take Note Have you read this article from the JDD? A new analysis uses Google Trends to shed light on…
Outdoor UV Exposure and Skin Cancer Risk: Why Occupational Protections Still Lag Behind This is a must-read article from JDD for dermatologists and dermatology healthcare professionals tracking skin cancer prevention…
Present at Skin of Color Update 2026 and Reach a Broader Audience Through JDD The Annual Skin of Color Update (SOCU) 2026 meeting in New York City is this fall,…
Join Janiene Luke, MD, to discover how MELAB3’s breakthrough active, Melasyl (2 MNG), intercepts melanin precursors before they form dark spots, setting a new standard for safety and efficacy across…